Javier Vázquez-Bourgon

Assistant Professor of Psychiatry

Universidad de Cantabria

Spain

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

LinkedIn ORCID

Google Scholar

Research Interests

Psychiatry

90%

Neuropsychology

40%

Psychoneuroimmunology

40%

Mental Illness

40%

Psychosis

40%

Neuropharmacology

30%

Polypharmacy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

The role of dopaMINE in bRain-liVer Axis in psychosis patients developing non-alcoholic fatty lIver diseae. The MINERVA study.

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Tratamiento estratificado en esquizofrenia: Integrando resultados de transcriptoma humano y celular en las estrategias de Tratamiento antipsicótico.

Open Date: 2019-04-01

Close Date: 2021-06-01

Articles11

Cross-sectional and longitudinal assessment of the association between DDR1 variants and processing speed in patients with early psychosis and healthy controls

Article Link

Year:

2023

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study

Article Link

Year:

2023

Intelligence quotient changes over 10 years: Diversity of cognitive profiles in first episode of psychosis and healthy controls.

Article Link

Year:

2023

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis.

Article Link

Year:

2023

Long-term mental health impact of COVID-19 on Primary Care health workers in northern Spain; results from a two-phase longitudinal study.

Article Link

Year:

2023

Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort

Article Link

Year:

2023

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis

Article Link

Year:

2022

Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals.

Article Link

Year:

2022

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial

Article Link

Year:

2022

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis

Article Link

Year:

2022

Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort

Article Link

Year:

2022

Collaborators15

Antonio Pardiñas

Lecturer

Cardiff University

UNITED KINGDOM

Antonin Skoch

Institute of Experimental Medicine

CZECH REPUBLIC

Gary Donohoe

Professor & chair of Psychology

National University of Ireland Galway

IRELAND

Karl David Neergaard

Research Professor

Tecnológico de Monterrey

SPAIN

James MacCabe

King’s College London

UNITED KINGDOM

Jorge Moya-Higueras

Associate professor

University of Lleida

SPAIN

Udo Dannlowski

University of Münster

GERMANY

Sean R. McWhinney

Dalhousie University

CANADA

Lourdes Martorell

Assistant professor

Universitat Rovira i Virgili

SPAIN

Thomas Weickert

Associate Professor

SUNY Upstate Medical University

UNITED STATES

vanessa sanchez-gistau

Associate professor

Universitat Rovira i Virgili

SPAIN

Sophie Smart

King’s College London

UNITED KINGDOM

Nancy Murillo-García

Instituto de Investigación Marqués de Valdecilla

SPAIN

Benedicto Crespo-Facorro

SPAIN

paolo brambilla

Associate Professor of Psychiatry

ITALY

How do I reach out?

Meet Kite AI